Home Cart Sign in  
Chemical Structure| 839707-37-8 Chemical Structure| 839707-37-8

Structure of Pluripotin
CAS No.: 839707-37-8

Chemical Structure| 839707-37-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Pluripotin is a dual inhibitor of extracellular signal-regulated kinase 1 (ERK1, MAPK3) and RasGAP. It maintains embryonic stem cell (ESC) self-renewal.

Synonyms: SC1

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Pluripotin

CAS No. :839707-37-8
Formula : C27H25F3N8O2
M.W : 550.54
SMILES Code : O=C(NC1=CC=C(C)C(N2CC3=CN=C(NC4=CC(C)=NN4C)N=C3N(C)C2=O)=C1)C5=CC=CC(C(F)(F)F)=C5
Synonyms :
SC1
MDL No. :MFCD20527253
InChI Key :NBZFRTJWEIHFPF-UHFFFAOYSA-N
Pubchem ID :12003241

Safety of Pluripotin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P280-P305+P351+P338

Related Pathways of Pluripotin

GPCR
MAPK

Isoform Comparison

Biological Activity

Target
  • ERK1

    ERK1, Kd:98 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
MV4-11 RASG12V 3.9 nM (IC50) 72 hours Inhibited proliferation of MV4-11 RASG12V cells
BaF3-FLT3ITD 8 nM (IC50) 72 hours Inhibited proliferation of BaF3-FLT3ITD cells PMC10125913
BaF3-BCR-ABL 12 nM (IC50) 72 hours Inhibited proliferation of BaF3-BCR-ABL cells PMC10125913
MV4-11 RASQ61K 3.8 nM (IC50) 72 hours Inhibited proliferation of MV4-11 RASQ61K cells
MOLM13 4.8 nM (IC50) 72 hours Inhibited proliferation of MOLM13 cells PMC10125913
MOLM13 RASG12V 3.8 nM (IC50) 72 hours Inhibited proliferation of MOLM13 RASG12V cells
MOLM13 RASQ61K 2.9 nM (IC50) 72 hours Inhibited proliferation of MOLM13 RASQ61K cells
BaF3-Jak2V617F 25 nM (IC50) 72 hours Inhibited proliferation of BaF3-Jak2V617F cells PMC10125913
BaF3-FLT3WT 7 nM (IC50) 72 hours Inhibited proliferation of BaF3-FLT3WT cells PMC10125913
MV4-11 4.0 nM (IC50) 72 hours Inhibited proliferation of MV4-11 cells PMC10125913

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
NSGS mice Human AML cell lines MOLM13 and MV4-11 xenograft model Intraperitoneal injection 15 mg/kg Daily, continuous treatment Pluripotin significantly extended the survival of NSGS mice transplanted with MOLM13 and MV4-11 cells and reduced leukemic burden PMC10125913

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.82mL

0.36mL

0.18mL

9.08mL

1.82mL

0.91mL

18.16mL

3.63mL

1.82mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories